These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine. Seagle EE, Bednarczyk RA, Hill T, Fiebelkorn AP, Hickman CJ, Icenogle JP, Belongia EA, McLean HQ. Vaccine; 2018 Feb 01; 36(6):818-826. PubMed ID: 29317117 [Abstract] [Full Text] [Related]
50. Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in health care workers and evaluation of a vaccination program in a tertiary care hospital in Japan. Asari S, Deguchi M, Tahara K, Taniike M, Toyokawa M, Nishi I, Watanabe M, Iwatani Y, Makimoto K. Am J Infect Control; 2003 May 01; 31(3):157-62. PubMed ID: 12734521 [Abstract] [Full Text] [Related]
51. Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: a randomized phase I/II clinical trial. Nakayama T, Eda M, Hirano M, Goto W. Hum Vaccin Immunother; 2019 May 01; 15(5):1139-1144. PubMed ID: 30724658 [Abstract] [Full Text] [Related]
53. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants. Spoulou V, Giannaki M, Vounatsou M, Bakoula C, Grafakos S. Bone Marrow Transplant; 2004 Jun 01; 33(12):1187-90. PubMed ID: 15077129 [Abstract] [Full Text] [Related]
55. Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India. Gohil DJ, Kothari ST, Chaudhari AB, Gunale BK, Kulkarni PS, Deshmukh RA, Chowdhary AS. Viral Immunol; 2016 Apr 01; 29(3):159-63. PubMed ID: 26910764 [Abstract] [Full Text] [Related]
56. Safety of measles, rubella and mumps vaccines in adults: a prospective cohort study. Ami N, Eyal N, Asaf B, Chen A, Adi B, Drorit A, Neta P, Hajar D, Stav R, Eli S. J Travel Med; 2021 Dec 29; 28(8):. PubMed ID: 34101817 [Abstract] [Full Text] [Related]
58. MMR vaccination, measles epidemiology and sero-surveillance in the Republic of Ireland. Johnson H, Hillary IB, McQuoid G, Gilmer BA. Vaccine; 1995 Apr 29; 13(6):533-7. PubMed ID: 7483773 [Abstract] [Full Text] [Related]
59. Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Vyse AJ, Gay NJ, Hesketh LM, Pebody R, Morgan-Capner P, Miller E. Epidemiol Infect; 2006 Dec 29; 134(6):1303-12. PubMed ID: 16650326 [Abstract] [Full Text] [Related]
60. Prevalence of measles, rubella, mumps, and varicella antibodies among healthcare workers in Japan. Hatakeyama S, Moriya K, Itoyama S, Nukui Y, Uchida M, Shintani Y, Morisawa Y, Kimura S. Infect Control Hosp Epidemiol; 2004 Jul 29; 25(7):591-4. PubMed ID: 15301032 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]